Technical420 Site Search

With Canada on the verge of legalizing recreational cannabis, more capital has entered the industry.One the most significant developments in 2015 was Justin Trudeau’s and the Liberal Party’s success in the Canadian general election. The outcome was a huge victory for the cannabis industry and a catalyst for Canadian cannabis…

One of the top performing cannabis stocks during 2016 has been Terra Tech Corp. (TRTC), a vertically integrated cannabis-focused agricultural company committed to cultivating and providing the highest quality medical cannabis and related products.TRTC has seen its share price rally by more than 420% during 2016 and shares continue to…

OrganiGram Holdings Inc. (OGI.V) (OGRMF) saw its shares rally after the company released a preliminary review of its second quarter results. During the quarter, OrganiGram reported more than $55,000 in net income and that it achieved positive year-to-date EBITDA and cash flow from operations.OrganiGram is a licensed medical marijuana producer…

MassRoots, Inc. (MSRT), the “Facebook of the marijuana industry” filed its S-1 Registration Statement in an offering to up-list onto the Nasdaq Capital Market exchange.In the application, MassRoots stated that they plan to list on the exchange under the symbol MSRT. The company should hear back from the exchange within…

In a letter to senators, the Drug Enforcement Administration said that they plan to decide whether marijuana should be reclassified under federal law in the first half of 2016.The letter was sent in response to a letter from Democratic Senator Elizabeth Warren (Massachusetts) and sever other Democratic Senators in 2015.…

The termination of the $160 billion merger between Pfizer Inc. (PFE) and Allergan Plc (AGN) has been confirmed.The driving factor behind this decision stems from the rules issued by the United States Treasury Department which are focused on making tax inversion deals less profitable.Moving Addresses, Not AssetsPresident Obama said the…

Earlier this month, GW Pharmaceuticals (GWPH) reported positive results from the first Phase 3 Clinical study for its Epidiolex product and this has served as a catalyst for several publicly traded cannabis companies.This rally can be described as nothing short of a volatile explosion upward as some of the stocks…